Bubble Gum-Flavored Children’s Advil Recall Issued Over Overdosing Risk

Due to a dosing error on the label, a recall has been issued for some “Bubble Gum” flavored children’s Advil bottles, which may result in a risk of overdose and potentially life-threatening injuries for children. 

The FDA announced the Children’s Bubble Gum flavored Advil recall on August 27, after concluding the dosage recommendations are marked in a different measurement than the dosage cup provided, which may result in confusion and overdosing errors.

The action was taken after the manufacturer, Pfizer Inc., received several consumer complaints about problems with the dosage cup provided with the medication, which is marked in teaspoons, even though the label instructions are described in milliliters. This could result in doses of the Advil being administered to children that are higher than what is safe.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Pfizer initiated an investigation after receiving the complaints and determined the mismatched dosing instructions pose a risk of overdosing, and initiated a recall.

Children’s Advil is specially formulated and is required to have dosing instructions based on a child’s age and weight. The over-the-counter medication is used to temporarily reduce fevers, relieve minor aches and pains due to the common cold, flu, and sore throat and relieve headaches and toothaches.

Children who are given too much Advil can run the risk of overdose which is known to cause nausea, vomiting, headache, drowsiness, blurred vision and dizziness. In severe cases of children’s Advil overdoses, symptoms of sudden fainting, hallucination, muscle tremors, slow irregular heartbeat and bluish lips or skin could occur.

The recall includes Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ bottles that are marked with NDC number 0573-0207-30, Lot number R51129, UPC number 3-0573-0207-30-0 and have an expiration date of November, 2020 printed in the MM/YY format.

The recalled children’s Advil was manufactured by Pfizer Inc., of New York City, New York where it was distributed nationwide to wholesalers, distributors and retailers in the United States from May 2018 through June 2018.

Pfizer has begun notifying wholesalers, distributors and retailers to check for any remaining inventory in stock or on store shelves and immediately quarantine the products and contact Stericycle at 1-800-805-3093 to arrange a pickup. Consumers should stop using the recalled Advil products immediately and either return them to their place of purchase or contact Pfizer Consumer Healthcare Information Line at 1-800-882-3845 for further information.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Family Seeks Remand of Bard Hernia Mesh Wrongful Death Lawsuit, After Global Settlement Negotiations “Have Dragged”
Family Seeks Remand of Bard Hernia Mesh Wrongful Death Lawsuit, After Global Settlement Negotiations “Have Dragged” (Posted today)

The Bard hernia mesh lawsuit has been pending for years in the federal MDL, where family indicates global settlement negotiations have stalled, leading to a request to allow their claim to be remanded for trial.

AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs
AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs (Posted yesterday)

Lawsuit blames PFAS manufacturers for failing to prevent water contamination by their chemicals, or warn municipalities and the public about the potential risks of ulcerative colitis and other diseases as a result of exposure.

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted 2 days ago)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.